The relationship between thyroid ultrasonography and cytopathology

Year 2021, Volume: 3 Issue: 2, 62 - 72, 29.04.2021

Aynur Arslan , Rabia Karasu Semiha Keskin Mehmet Nail Güngör

https://doi.org/10.46310/tjim.822949

Abstract

Introduction: Thyroid fine needle aspiration biopsy (FNAB) is performed under ultrasound guidance to make a diagnosis. According to EU-TIRADS (European Thyroid Imaging and Reporting Data System) category, the morphologic characteristics of the nodule is described. Histopathological results are classified according to the Bethesda system. In this single centre, retrospective study, to investigate which EU-TIRADS groups had no malignancy as a result of FNAB was aimed.
Methods: Ultrasonography findings and pathology reports of the patients whom FNAB was performed at the State Hospital between January 2016 and December 2018 were reviewed. 251 patients (201 female, 50 male) who were over 18 years of age (mean age 52.62 ± 12.29) were included.
Ultrasonographic findings were classified according to EU-TIRADS. Distribution of EU-TİRADS categories by Bethesda Classification was shown. Frequency tables, descriptive statistics, Kruskal-Wallis H test, and cross-tabulation were used. The analysis was performed using SPSS 25.0.
Ethics Committee approval and written informed consent were obtained.
Results: Of the 7 cases in Bethesda group V, which were ‘Suspicious for papillary carcinoma’, 42.9% were in ‘High-Risk Category’in EU-TIRADS and 57.1% were in ‘Intermediate-Risk Category’.
No benign cases in EU-TIRADS were in Bethesda IV, V and VI groups.
Conclusions: None of the benign cases in EU-TIRADS were found to be in the Bethesda IV-V-VI groups. By carrying out studies with larger number of cases, it can be investigated whether it will be considered safe to follow-up the cases in benign EU-TIRADS group without applying FNAB.

Keywords

thyroid, ultrasonography, biopsy, needle, pathology

References

• Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L. European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS. Eur Thyroid J. 2017 Sep;6(5):225–37. doi:10.1159/000478927.
• Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE,Pacini F, RandolphGW, SawkaAM, SchlumbergerM, SchuffKG, Sherman SI, Sosa JA,Steward DL, Tuttle RM, WartofskyL. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1–133. doi:10.1089/thy.2015.0020.
• Shin JH, Baek JH, Chung J, Ha EJ, Kim JH, Lee YH,Lim HK, Moon WJ, Na DG, Park, JS, Choi YJ, Hahn SY, Jeon SJ, Jung SL, Kim DW, Kim EK, Kwak JY, Lee CY, Lee HJ, Lee JH, Lee JH, Lee KH, Park SW, Sung JY. Ultrasonography diagnosis and imaging-based management of thyroid nodules: Revised Korean society of thyroid radiology consensus statement and recommendations. Korean J Radiol. 2016 May-June;17(3):37. doi: 10.3348/kjr.2016.17.3.370.
• Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. J. Am. Soc. Cytopathol. 2017 Sep;6(6):217-22. doi: 10.1016/j.jasc.2017.09.002.
• Barile A, Quarchioni S, Bruno F, Ierardi AM, Arrigoni F, Giordano AV,Carducci S, VarrassiM, Carrafiello G, CaranciF, Splendiani A, Cesare ED, MasciocchiC. Interventional radiology of the thyroid gland: Critical review and state of the art. Gland Surg. 2018 Apr;78(2): 132-146.doi: 10.21037/gs.2017.11.17.
• Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, Cronan JJ, Beland MD, Desser TS, Frates MC, Hammers LW, Hamper UM, Langer JE, Reading CC, ScouttLM , Stavros AT. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol. 2017 May;14(5):587–95.doi:10.1016/j.jacr.2017.01.046.
• Li F, Pan D, Wu Y, Peng J, Li Q, Gui X, Ma W, Yang H, He Y, Chen J.. Ultrasound characteristics of thyroid nodules facilitate interpretation of the malignant risk of Bethesda system III/IV thyroid nodules and inform therapeutic schedule. Diagn Cytopathol. 2019 June;47(9):881–9. doi:10.1002/dc.24248.
• Raj SD, Ram R, Sabbag DJ, Sultenfuss MA, Matejowsky R. Thyroid Fine Needle Aspiration: Successful Prospective Implementation of Strategies to Eliminate Unnecessary Biopsy in the Veteran Population. Curr Probl Diagn Radiol. 2019Mar–Apr;48(2):127–31. doi:10.1067/j.cpradiol.2017.12.003.
• Kim EK, Cheong SP, Woung YC, Ki KO, Dong IK, Jong TL,Yoo HS. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. Am J Roentgenol. 2002Mar;178(3):687–91. doi:10.2214/ajr.178.3.1780687.
• De Ycaza AEE, Lowe KM, Dean DS, Castro MR, Fatourechi V, Ryder M, Morris SJ,Stan MN. Risk of malignancy in thyroid nodules with non-diagnostic fine-needle aspiration: A retrospective cohort study. Thyroid. 2016Nov;26(11):1598–604.doi:10.1089/thy.2016.0096.
• Malhi H, Velez E, Kazmierski B, Gulati M, Deurdulian C, Cen S, Grant EG. Peripheral Thyroid Nodule Calcifications on Sonography: Evaluation of Malignant Potential. Am J Roentgenol. 2019Sep;213(3):672-5. doi:10.2214/AJR.18.20799.
• Kamran SC, Marqusee E, Kim MI, Frates MC, Ritner J, Peters H,BensonCB, DoubiletPM, Cibas ES, Barletta,J Nancy Cho, Atul Gawande, Daniel Ruan, Francis D Moore Jr, Karla Pou, P Reed Larsen, Erik K Alexander. Thyroid nodule size and prediction of cancer. J Clin Endocrinol Metab. 2013Feb;98(2):564–70.doi:10.1210/jc.2012-2968.
• Kiernan CM, Solórzano CC. Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy? J Am Coll Surg. 2017July;225(1):77–82. doi:10.1016/j.jamcollsurg.2017.02.002.
• Hong MJ, Na DG, Baek JH, Sung JY, Kim JH. Impact of nodule size on malignancy risk differs according to the ultrasonography pattern of thyroid nodules. Korean J Radiol. 2018 May-June;19(3):534–41. doi:10.3348/kjr.2018.19.3.534.
• Zhao L, Yan H, Pang P, Fan X, Jia X, Zang L, Luo Y, Wang F, Yang G, Gu W, Du J, Wang X, Lyu Z, Dou J, Mu Y. Thyroid nodule size calculated using ultrasound and gross pathology as predictors of cancer: A 23year retrospective study. Diagn Cytopathol. 2019Mar;47(3):187–93. doi:10.1002/dc.24068.
• Ramundo V, Lamartina L, Falcone R, Ciotti L, Lomonaco C, Biffoni M, Giacomelli L, Maranghi M, Durante C, Grani G. Is thyroid nodule location associated with malignancy risk? Ultrasonography. 2019Jul;38(3):231–5. doi:10.14366/usg.18050.
• Zhang F, Oluwo O, Castillo FB, Gangula P, Castillo M, Farag F, Zakaria S, Zahedi T. Thyroid nodule location on ultrasonography as a predictor of malignancy. Endocr Pr. 2019Feb;25(2):131–7. doi:10.4158/EP-2018-0361.
• Wettasinghe M, Rosairo S, Ratnatunga N, Wickramasinghe N. Diagnostic accuracy of ultrasound characteristics in the identification of malignant thyroid nodules. BMC Res Notes. 2019Apr;12(1):193.doi:10.1186/s13104-019-4235-y.
• Nabahati M, Moazezi Z, Fartookzadeh S, Mehraeen R, Ghaemian N, Sharbatdaran M. The comparison of accuracy of ultrasonographic features versus ultrasound-guided fine-needle aspiration cytology in diagnosis of malignant thyroid nodules. J Ultrasound. 2019Sep;22(3):315-21. doi:10.1007/s40477-019-00377-2.
• Ligha AE, Pidlaoan R. The Accuracy of Risk Stratification System for Classifying Thyroid Nodules in EU-NRMF, Medical Center. FASEB J. 2019Apr;33(S1):453. doi:10.1096/fasebj.2019.33.1_supplement.453.10
• Ma JJ, Ding H, Xu BH, Xu C, Song LJ, Huang BJ, WangW. Diagnostic performances of various gray-scale, color Doppler, and contrast-enhanced ultrasonography findings in predicting malignant thyroid nodules. Thyroid. 2014Feb;24(2):355–63. doi:10.1089/thy.2013.0150.
• Frates MC, Benson CB, Doubilet PM, Cibas ES, Marqusee E. Can color doppler sonography aid in the prediction of malignancy of thyroid nodules? J Ultrasound Med. 2003Feb;22(2):127–31. doi:10.7863/jum.2003.22.2.127.
• Triantafillou E, Papadakis G, Kanouta F, Kalaitzidou S, Drosou A, Sapera A, TampouratziD, Kotis M, Kyrimis T, DracopoulouA, VeniouE, KaravasiliC, KaltzidouV, PlytaS, TertipiA. Thyroid ultrasonographic charasteristics and Bethesda results after FNAB. J Balk Union Oncol. 2018Dec;23:139–43.PMID: 30722123
• Popoveniuc G, Jonklaas J. Thyroid Nodules. Med Clin North Am. 2012Mar;96(2):329–49.doi: 10.1016/j.mcna.2012.02.002.
• Alshaikh S, Harb Z, Aljufairi E, Almahari SA. Classification of thyroid fine-needle aspiration cytology into Bethesda categories: An institutional experience and review of the literature. CytoJournal[serial online]. 2018Feb;15(4):1.doi:10.4103/cytojournal.cytojournal_32_17.
• Xie C, Cox P, Taylor N, LaPorte S. Ultrasonography of thyroid nodules: a pictorial review. Insights Imaging. 2016 Nov;7(1):77–86. doi:10.1007/s13244-015-0446-5.
• Periakaruppan G, Seshadri KG, Vignesh Krishna GM, Mandava R, Venkata Sai PM, Rajendiran S. Correlation between ultrasound-based TIRADS and Bethesda system for reporting thyroid-cytopathology: 2-year experience at a tertiary care center in India. Indian J Endocrinol Metab. 2018 Sep;22(5):651–5. doi:10.4103/ijem.IJEM_27_18.